|
|
 |
| Sell |
Product |
CAS |
Date |
More |
| Sell |
GSK-2816126 |
1346574-57-9 |
2018-07-20 |
|
| Sell |
EPZ-6438; Tazemetostat |
1403254-99-8 |
2018-07-20 |
|
| Sell |
AZD-3759 |
1626387-80-1 |
2018-07-20 |
|
| Sell |
(S)-4-bromo-2,3-dihydro-1H-inden-1-amine hydrochloride |
1307873-37-5 |
2018-07-20 |
|
| Sell |
(Z)-N-(4-bromo-2,3-dihydro-1H-inden-1-ylidene)-2-methylpropane-2-sulfinamide |
1307873-35-3 |
2018-07-20 |
|
| Sell |
N-((S)-4-bromo-2,3-dihydro-1H-inden-1-yl)-2-methylpropane-2-sulfinamide |
1307231-20-4 |
2018-07-20 |
|
| Sell |
methyl (diethoxyphosphoryl)formate |
41760-84-3 |
2018-07-20 |
|
| Sell |
(R)-benzyl (2-oxoazepan-3-yl)carbamate |
103478-12-2 |
2018-07-20 |
|
| Sell |
Retagliptin; SP-2086 |
1174122-54-3 (free base); 1256756-88-3 (phosphate) |
2018-07-20 |
|
| Sell |
GSK2982772 |
1622848-92-3 |
2018-07-20 |
|
| Sell |
GSK2256098; GTPL7939 |
1224887-10-8 |
2018-07-20 |
|
| Sell |
2-(1-(6-chloro-2,5-dimethylpyrimidin-4-yl)piperidin-4-yl)-1,5,6,7-tetrahydro-1,8-naphthyridine |
NA |
2018-07-20 |
|
| Sell |
2-(piperidin-4-yl)-1,5,6,7-tetrahydro-1,8-naphthyridine |
315240-28-9(Free base), 206989-64-2(2HCl), 692247- |
2018-07-20 |
|
| Sell |
tert-butyl 4-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)piperidine-1-carboxylate |
206989-63-1 |
2018-07-20 |
|
| Sell |
tert-butyl 4-(1,8-naphthyridin-2-yl)piperidine-1-carboxylate |
206989-62-0 |
2018-07-20 |
|
|
